AptaTargets

Madrid, Spain Founded: 2014 • Age: 12 yrs
Provider of therapeutic solutions for ischemic diseases
Request Access

About AptaTargets

AptaTargets is a company based in Madrid (Spain) founded in 2014.. AptaTargets has raised $2.98 million across 2 funding rounds from investors including EIT Health, Inveready and Caixa Capital Risc. AptaTargets offers products and services including ApTOLL. AptaTargets operates in a competitive market with competitors including Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others.

  • Headquarter Madrid, Spain
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Aptatargets Sl
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Healthcare → Healthcare Products & Supplies
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $2.98 M (USD)

    in 2 rounds

  • Latest Funding Round
  • Investors
    EIT Health

    & 2 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of AptaTargets

AptaTargets offers a comprehensive portfolio of products and services, including ApTOLL. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Blocks TLR4 activation to treat acute ischemic stroke and inflammation.

People of AptaTargets
Headcount 1-10
Employee Profiles 6
Board Members and Advisors 9
Employee Profiles
People
Macarena Hernández
CSO
People
David Saxner
Chief Business Officer
People
David Segarra
Co-Founder, Director & CEO
People
Marc Ribó
CMO

Unlock access to complete

Board Members and Advisors
people
Ignacio Lizasoain
Advisor
people
Mads Dalsgaard
Independent Board Member
people
Joaquín Casariego
Advisor
people
Marco Moreno
Advisor

Unlock access to complete

Funding Insights of AptaTargets

AptaTargets has successfully raised a total of $2.98M across 2 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 2
  • Last Round
  • First Round

    (17 May 2017)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2018 Amount Grant - AptaTargets Valuation

investors

May, 2017 Amount Series A - AptaTargets Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in AptaTargets

AptaTargets has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include EIT Health, Inveready and Caixa Capital Risc. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Investor Description Founded Year Domain Location
Healthcare startups are accelerated and incubated through specialized programs.
Founded Year Domain Location
Inveready is recognized as a leading Spanish financial services firm.
Founded Year Domain Location
Venture capital investments are focused on healthcare and multiple sectors.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by AptaTargets

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - AptaTargets

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Aptatargets Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of AptaTargets

AptaTargets operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, GRAIL, Foundation Medicine, ArcherDX and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Digital sequencing technology for cancer detection is developed.
domain founded_year HQ Location
Circulating tumor DNA is screened for early cancer detection.
domain founded_year HQ Location
Genomics-based diagnostic tests for cancer are provided.
domain founded_year HQ Location
Molecular cancer diagnostic products are developed using patented AMP technology.
domain founded_year HQ Location
Developer of cell-free DNA testing for oncology, women’s health, and organ health
domain founded_year HQ Location
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Aptatargets

Frequently Asked Questions about AptaTargets

When was AptaTargets founded?

AptaTargets was founded in 2014 and raised its 1st funding round 3 years after it was founded.

Where is AptaTargets located?

AptaTargets is headquartered in Madrid, Spain. It is registered at Madrid, Madrid, Spain.

Is AptaTargets a funded company?

AptaTargets is a funded company, having raised a total of $2.98M across 2 funding rounds to date. The company's 1st funding round was a Series A of $2.98M, raised on May 17, 2017.

What does AptaTargets do?

AptaTargets is a provider of therapeutic solutions for ischemic diseases. It has developed ApTOLL product that consists of DNA aptamers with a specific 3D conformation. It will enable TL-4 antagonistic response for controlling the inflammatory response. The first application is the treatment of ischemic stroke. The candidate is currently completing preclinical studies.

Who are the top competitors of AptaTargets?

AptaTargets's top competitors include Guardant Health, GRAIL and Strand Life Sciences.

What products or services does AptaTargets offer?

AptaTargets offers ApTOLL.

Who are AptaTargets's investors?

AptaTargets has 3 investors. Key investors include EIT Health, Inveready, and Caixa Capital Risc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available